Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
暂无分享,去创建一个
J. Grotta | J. Jeng | S. Johnston | P. Amarenco | Yilong Wang | Yongjun Wang | P. Bath | T. Simon | Liping Liu | David Wang | Yuesong Pan | Hao Li | K. Wong | J. S. Kim | Yi Lin
[1] S. Johnston,et al. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. , 2016, The New England journal of medicine.
[2] J. Grotta. Antiplatelet Therapy after Ischemic Stroke or TIA. , 2018, The New England journal of medicine.
[3] Hao Li,et al. Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial , 2016, Stroke and Vascular Neurology.
[4] Hao Li,et al. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial , 2018, JAMA neurology.
[5] Tammy Hoffmann,et al. Clinical Guidelines for Stroke Management 2010 , 2010 .
[6] K. Butcher,et al. Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018 , 2018, International journal of stroke : official journal of the International Stroke Society.
[7] S. Johnston,et al. Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis , 2017, Circulation.
[8] C. Coffey,et al. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. , 2012, The New England journal of medicine.
[9] G. Guyatt,et al. Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline , 2018, British Medical Journal.
[10] Liping Liu,et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. , 2013, The New England journal of medicine.
[11] R. Conwit,et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA , 2018, The New England journal of medicine.
[12] 김용권,et al. 뇌졸중 환자의 임상적 검사NIHSS(National Institutes of Health Stroke Scale)와 기능적 예후와의 상관관계 , 2002 .
[13] Ming Liu,et al. 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack , 2017, International journal of stroke : official journal of the International Stroke Society.
[14] M. Wintermark,et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.
[15] S. Kasner,et al. Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial , 2017, The Lancet Neurology.
[16] S. Johnston,et al. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. , 2016, The New England journal of medicine.
[17] R. Conwit,et al. The Secondary Prevention of Small Subcortical Strokes (SPS3) Study , 2011, International journal of stroke : official journal of the International Stroke Society.
[18] G. Guyatt,et al. Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis , 2018, British medical journal.
[19] Yilong Wang,et al. Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis , 2018, Stroke and Vascular Neurology.
[20] H. H. Jensen,et al. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial , 2017, The Lancet.